Search Clinical Trials

598,193 trials

NCT07762443
Not Yet RecruitingPhase 1
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia AreataJiangsu vcare pharmaceutical technology co., LTD
NCT07763067
CompletedNot Applicable
Acceptability and Outcomes of an Online Parent-Mediated Intervention for Young Autistic ChildrenHerguner Therapy Private Clinic
NCT07762144
Enrolling By Invitation
Clinical Cohort Construction Program of Peking University Third HospitalPeking University Third Hospital
NCT07762716
Not Yet RecruitingPhase 1
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio Corp
NCT07762014
Not Yet RecruitingPhase 2
rBCG-N-RSV Vaccine in Adults Aged 60 Years and OlderBiothervax SpA
NCT07764250
RecruitingNot Applicable
Comparative Evaluation of Immediate vs Progressive Standing Dual Task Training in Elderly With Mild and Moderate Cognitive ImpairmentShifa Tameer-e-Millat University
NCT07762989
Not Yet Recruiting
Donor Ankle Sensorimotor Recovery After ACL Reconstruction With a Peroneus Longus Tendon AutograftGazi University
NCT07763145
Not Yet RecruitingNot Applicable
Effect of Citicoline on Neurological Severity Score and Cerebral Doppler Resistive Index in Neonatal Hypoxic Ischemic Encephalopathy: A Randomized Control TrialHayatabad Medical Complex
NCT07764198
RecruitingNot Applicable
A Randomized Controlled Trial of Gabor-Based Perceptual Learning for Adult AmblyopiaJiannan Huang
NCT07762924
RecruitingPhase 2
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving SurgeryFudan University
NCT07763938
Not Yet RecruitingPhase 1
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNanjing Legend Biotech Co.
NCT07762703
Not Yet RecruitingPhase 1
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio Corp
NCT07764016
Not Yet RecruitingNot Applicable
DCB Outcomes After Non-Compliant Balloon Vessel Preparation With or Without Scoring in Patients With Femoropopliteal Arterial DiseaseCardionovum GmbH
NCT07762794
Not Yet RecruitingPhase 4
Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World Setting in Patients With Extremity Arterial Injury Requiring Urgent RepairHumacyte, Inc.
NCT07762586
RecruitingPhase 2
Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)Rutgers, The State University of New Jersey
NCT07762469
Not Yet Recruiting
Diagnostic Performance of a Flexible Penile Monitoring System for EDBin Xu
NCT07762274
Completed
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke and Brain Injury, Further Validation of RehAtt® DiSTRO Assessment of Cognitive and Visual FunctionDepartment of clinical sciences at Danderyd hospital
NCT07764406
CompletedNot Applicable
Effect Of Amniotomy In Early Labour On Duration Of LabourIndus Hospital and Health Network
NCT07763210
Not Yet RecruitingPhase 2
Lazarus: IT Therapy for ICANSGilead Sciences
NCT07764003
Not Yet RecruitingPhase 2
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to 2nd-generation H1-AHsHangzhou Highlightll Pharmaceutical Co., Ltd